CDAX
1.815,96
PKT
-11,04
PKT
-0,60
%
Werbung
Analysen zu CDAX-Werten
Datum | Rating | Analyst | |
---|---|---|---|
29.11.22 | CEWE Stiftung Add | Baader Bank | |
29.11.22 | Brenntag Neutral | UBS AG | |
29.11.22 | Aurubis Add | Baader Bank | |
29.11.22 | Fresenius Overweight | Barclays Capital | |
29.11.22 | Brenntag Buy | Deutsche Bank AG | |
29.11.22 | Lufthansa Underperform | Bernstein Research | |
29.11.22 | Fresenius Medical Care (FMC) St. Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
29.11.22 | RWE Outperform | RBC Capital Markets | |
29.11.22 | Uniper Sell | UBS AG | |
29.11.22 | Delivery Hero Outperform | Bernstein Research | |
29.11.22 | Brenntag Overweight | JP Morgan Chase & Co. | |
28.11.22 | thyssenkrupp Halten | DZ BANK | |
28.11.22 | RWE Overweight | Barclays Capital | |
28.11.22 | CENIT Kaufen | GBC | |
28.11.22 | FUCHS Neutral | UBS AG | |
28.11.22 | Covestro Neutral | UBS AG | |
28.11.22 | BASF Sell | UBS AG | |
28.11.22 | WACKER CHEMIE Neutral | UBS AG | |
28.11.22 | Evonik Neutral | UBS AG | |
28.11.22 | LANXESS Buy | UBS AG | |
28.11.22 | Symrise Buy | UBS AG | |
28.11.22 | K+S Neutral | UBS AG | |
28.11.22 | USU Software Kaufen | GBC | |
28.11.22 | BASF Neutral | Goldman Sachs Group Inc. | |
28.11.22 | Covestro Buy | Goldman Sachs Group Inc. | |
28.11.22 | Evonik Sell | Goldman Sachs Group Inc. | |
28.11.22 | United Internet Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
28.11.22 | E.ON Market-Perform | Bernstein Research | |
28.11.22 | RWE Outperform | Bernstein Research | |
28.11.22 | Fresenius Medical Care (FMC) St. Neutral | UBS AG | |
28.11.22 | K+S Hold | Deutsche Bank AG | |
28.11.22 | thyssenkrupp Hold | Deutsche Bank AG | |
28.11.22 | Talanx Hold | Deutsche Bank AG | |
28.11.22 | Brenntag Overweight | JP Morgan Chase & Co. | |
28.11.22 | Carl Zeiss Meditec Buy | UBS AG | |
28.11.22 | Vonovia Buy | UBS AG | |
28.11.22 | Siemens Healthineers Buy | UBS AG | |
28.11.22 | Brenntag Buy | Goldman Sachs Group Inc. | |
28.11.22 | Brenntag Buy | Warburg Research | |
28.11.22 | thyssenkrupp Underweight | Barclays Capital |